AdaptHealth Corp. (NASDAQ: AHCO) disclosed that director Kenneth A. Samet purchased 23,500 shares of the company's common stock on August 6, 2026 at $6.38 per share, amounting to a total transaction value of $149,930. Following this direct acquisition, Samet beneficially owns 48,569 AdaptHealth shares. At the time of reporting, AHCO shares were trading near their 52‑week low of $5.21, below the purchase price, while InvestingPro's fair‑value estimate stands at $7.89.
In its second‑quarter 2026 results, AdaptHealth reported an adjusted loss of $0.99 per share, missing analysts' consensus expectation of a $0.15 profit. Quarterly revenue was $740.3 million, short of the $848.9 million forecast, although it represented a 12.7 % increase year‑over‑year. The company attributed the earnings shortfall to higher costs associated with a major West Coast capitated contract, a manufacturer price increase, and portfolio changes.
Truist Securities responded to the earnings miss by lowering its price target for AdaptHealth from $14.00 to $9.00 while maintaining a Buy rating, citing the profitability challenges arising from the identified cost pressures.